January 22, 2021 (Resource) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXD) (“Hemostemix” or the “Business“) is delighted to announce it has signed the Building Interactions Business owners & Dealmakers (BREAD) contract with the Office of Foreign Affairs, Trade and Growth. An initiative to guide substantial-probable, biotech focused Canadian Small and Medium Company (SMEs), the method is designed to accelerate the growth of Hemostemix and other Canadian biotechnology businesses.
“We are actively functioning with the Trade Commissioner Provider of CANADA in the United states, Japan and South Korea to resource experienced partners to go to marketplace with,” stated Thomas Smeenk, CEO. “The BREAD settlement marks our Company’s starting up position to out-license ACP-01, and it generates our sponsorship into BioCom.”
ABOUT THE TRADE COMMISSIONER Provider OF CANADA
The Trade Commissioner Support (TCS) performs an lively job in encouraging Canadian companies reach their objectives of expansion